Published • loading... • Updated
SFDA approves first daily oral weight-loss drug for adults with obesity
Summary by Saudi Gazette
1 Articles
1 Articles
SFDA approves first daily oral weight-loss drug for adults with obesity
RIYADH — The Food and Drug Authority (SFDA) has approved the registration of Foundaio, a once-daily oral medication to support long-term weight loss and weight maintenance in adults with obesity or overweight accompanied by at least one weight-related medical condition.The drug contains the active ingredient orforglipron and is intended to be used alongside a healthy diet and regular physical activity.According to the SFDA, Foundaio works by act…
·Jeddah, Saudi Arabia
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
